Your browser doesn't support javascript.
loading
Clinical observation of early intravesical instillation of pirarubicin after transurethral resection of bladder tumor and psychological intervention to patients / 中国生化药物杂志
Article in Zh | WPRIM | ID: wpr-659896
Responsible library: WPRO
ABSTRACT
Objective To discuss the clinical effect of early bladder instillation of pirarubicin after transurethral resection of bladder tumor and the psychological intervention measures. Methods 86 patients from August 2015 to December 2016 for transurethral resection of bladder tumor treated with pirarubicin(PHT) early intravesical therapy were divided randomly into experimental group 43 cases and control group 43 cases, control group in transurethral resection of bladder tumor after transurethral resection take the routine drug regimen, early implementation of pirarubicin therapy after surgery in the experimental group, to compare and analyze the recurrence of bladder cancer after operation in the two groups, and two groups of patients were given psychological nursing, to explore the implementation and effect of psychological nursing measures. Results The patients in the experimental group the recurrence rate was 9.3%, significantly higher than the control group 18.6%, the differences between groups was statistically significant (P<0.05); two groups of patients were given psychological nursing was found to improve patient psychological treatment, increase treatment compliance. Conclusion THP in transurethral resection of bladder tumor after star early bladder irrigation can effectively reduce the recurrence rate of bladder cancer after operation, psychological nursing in the treatment process, can enhance the tolerance in the treatment of patients, improve the treatment compliance, is worthy of clinical popularization and application.
Key words
Full text: 1 Index: WPRIM Language: Zh Journal: Chinese Journal of Biochemical Pharmaceutics Year: 2017 Type: Article
Full text: 1 Index: WPRIM Language: Zh Journal: Chinese Journal of Biochemical Pharmaceutics Year: 2017 Type: Article